Healthcare provider profile · identity verified

Matthew Braig, D.O.

Family Practice · PHOENIX, AZ · NPI 1356705610

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	479	159
Levothyroxine Sodium	Levothyroxine Sodium	444	128
Lisinopril	Lisinopril	317	113
Amlodipine Besylate	Amlodipine Besylate	275	94
Losartan Potassium	Losartan Potassium	251	84
Rosuvastatin Calcium	Rosuvastatin Calcium	239	76
Omeprazole	Omeprazole	161	55
Simvastatin	Simvastatin	157	46
Gabapentin	Gabapentin	156	55
Trazodone Hcl	Trazodone Hcl	151	52
Pantoprazole Sodium	Pantoprazole Sodium	128	42
Meloxicam	Meloxicam	127	49
Metoprolol Succinate	Metoprolol Succinate	125	45
Tamsulosin Hcl	Tamsulosin Hcl	120	42
Famotidine	Famotidine	118	38
Metformin Hcl	Metformin Hcl	118	38
Fluticasone Propionate	Fluticasone Propionate	114	56
Hydrochlorothiazide	Hydrochlorothiazide	114	39
Ozempic	Semaglutide	111	24
Metformin Hcl Er	Metformin Hcl	108	38
Escitalopram Oxalate	Escitalopram Oxalate	106	34
Albuterol Sulfate Hfa	Albuterol Sulfate	89	31
Duloxetine Hcl	Duloxetine Hcl	87	32
Allopurinol	Allopurinol	83	30
Sertraline Hcl	Sertraline Hcl	81	29
Methylprednisolone	Methylprednisolone	79	68
Celecoxib	Celecoxib	70	26
Mounjaro	Tirzepatide	67	21
Testosterone Cypionate	Testosterone Cypionate	67	20
Furosemide	Furosemide	66	21
Atenolol	Atenolol	65	18
Hydroxyzine Hcl	Hydroxyzine Hcl	64	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	62	18
Zolpidem Tartrate	Zolpidem Tartrate	62	22
Ezetimibe	Ezetimibe	60	19
Farxiga	Dapagliflozin Propanediol	60	15
Tramadol Hcl	Tramadol Hcl	60	24
Lorazepam	Lorazepam	54	14
Potassium Chloride	Potassium Chloride	52	22
Clonazepam	Clonazepam	49	11
Carvedilol	Carvedilol	48	14
Glimepiride	Glimepiride	48	17
Jardiance	Empagliflozin	48	14
Montelukast Sodium	Montelukast Sodium	47	18
Buspirone Hcl	Buspirone Hcl	45	12
Tizanidine Hcl	Tizanidine Hcl	45	25
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	44	20
Pravastatin Sodium	Pravastatin Sodium	44	17
Clopidogrel	Clopidogrel Bisulfate	43	13
Eliquis	Apixaban	43	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	15
Amitriptyline Hcl	Amitriptyline Hcl	40	14
Valsartan	Valsartan	39	12
Bupropion Xl	Bupropion Hcl	38	15
Alendronate Sodium	Alendronate Sodium	37	13
Finasteride	Finasteride	35	12
Synthroid	Levothyroxine Sodium	35	suppressed
Ondansetron Hcl	Ondansetron Hcl	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	17
Doxazosin Mesylate	Doxazosin Mesylate	32	14
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Spironolactone	Spironolactone	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	14
Ondansetron Odt	Ondansetron	30	14
Oxybutynin Chloride Er	Oxybutynin Chloride	30	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	14
Metoprolol Tartrate	Metoprolol Tartrate	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	15
Diclofenac Sodium	Diclofenac Sodium	26	15
Donepezil Hcl	Donepezil Hcl	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Estradiol	Estradiol	23	12
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Rizatriptan	Rizatriptan Benzoate	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Acyclovir	Acyclovir	21	11
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	21	suppressed
Glipizide	Glipizide	21	suppressed
Naproxen	Naproxen	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	17
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Azithromycin	Azithromycin	19	16
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Ciclopirox	Ciclopirox	17	suppressed
Diazepam	Diazepam	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	16
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Glipizide Er	Glipizide	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Temazepam	Temazepam	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Ramipril	Ramipril	13	suppressed
Topiramate	Topiramate	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Baclofen	Baclofen	12	suppressed
Colchicine	Colchicine	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	12
Trulicity	Dulaglutide	12	suppressed
Azelaic Acid	Azelaic Acid	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Prednisone	Prednisone	11	suppressed
Telmisartan	Telmisartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error